Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now
Posted on April 26th, 2016 by Betsy Davis in Pharmacovigilance
A few weeks ago, the US FDA approved Inflectra (infliximab-dyyb), a biosimilar to infliximab. This is the second US biosimilar approval, suggesting others may soon be on the way—good news for companies with biosimilars pending approval and in development. (more…)